Objectives To investigate whether physical exposure parameters such as the dose index (CTDI), dose length product (DLP), and size-specific dose estimate (SSDE) are predictive of DNA damage. Methods In vitro, we scanned a phantom containing blood samples from five volunteers at CTDI 50, 100, and 150 mGy. One sample was not scanned. We also scanned samples in three different-size phantoms at CTDI 100 mGy. In vivo, we enrolled 45 patients and obtained blood samples before and after cardiac CT. The γ-H2AX foci were counted. Results In vitro, in the control and at CTDI 50, 100, and 150 mGy, the number of γ-H2AX was 0.94 ± 0.24 (standard error, SE), 1.28 ± 0.30, 1.91 ± 0.47, and 2.16 ± 0.20. At SSDE 180, 156, and 135 mGy, it was 2.41 ± 0.20, 1.91 ± 0.47, and 1.42 ± 0.20 foci/cell. The γ-H2AX foci were positively correlated with the radiation dose and negatively correlated with the body size. In vivo, the γ-H2AX foci were significantly increased after CT (from 1.21 ± 0.19 to 1.92 ± 0.22 foci/cell) and correlated with CTDI, DLP, and SSDE. Conclusions DNA damage was induced by cardiac CT. There was a correlation between the physical exposure parameters and γ-H2AX. Key Points • DNA damage was induced by radiation exposure from cardiac CT.
Introduction
The number of CT examinations has drastically increased over the past few years and whole-body CT screening and cardiac and perfusion CT studies of whole organs are now widely performed [1] [2] [3] [4] [5] . Consequently, CT is now the largest source of radiation exposure in diagnostic imaging [6, 7] and the risk of cancer from CT is a rising concern in the medical community [8] [9] [10] [11] .
Since the increase in the cancer risk is correlated with the radiation dose, the precise estimation of the cancer risk from medical procedures involving radiation such as CT scanning is needed. The CT dose index (CTDI), the dose length product (DLP), and size-specific dose estimates (SSDEs) are widely used as the physical exposure parameters at CT. As the CTDI and DLP are displayed on CT scanners, they can be confirmed at each scan. However, the CTDI or the DLP is an index of the radiation output of the CT system; neither corresponds directly with the radiation dose delivered to each patient [12] . The SSDE is an index in which the CTDI is corrected by the size and shape of each patient [13, 14] . Therefore it may be a better estimate of the actual radiation dose than the CTDI or DLP; however, the SSDE is also not the direct dose received by the body.
DNA damage is induced by radiation exposure [15, 16] , and it can result in cell death and trigger genomic instability and the development of cancer [17] . The phosphorylation of the histone variant H2AX, termed γ-H2AX, has gained attention as a biomarker of DNA damage induced by radiation exposure. Immunofluorescent techniques using a γ-H2AX antibody facilitate visualisation of discrete nuclear foci at the site of DNA damage [7, 15] . The purpose of this study was to investigate whether certain physical exposure parameters such as the CTDI, DLP, and SSDE were correlated with DNA damage induced by CT radiation.
Materials and methods
This study was approved by our institutional review board. Prior written informed consent was obtained from all volunteers and patients.
Measurement of γ-H2AX foci
Cytologically visible foci were used as an indicator of DNA damage. Immunofluorescent staining for γ-H2AX foci was performed as described previously [18] . Briefly, circulating mononuclear cells (MNCs) isolated by using Lymphoprep according to the manufacturer's instructions were placed on glass slides for subsequent immunofluorescent analysis. The cells were fixed with 4% paraformaldehyde; their nuclei were permeabilised with Triton X-100. The cells were then incubated with anti-γ-H2AX antibody for 30 min at 37°, followed by incubation with Cy3-conjugated secondary antibodies (30 min at 37°). Nuclei were stained with Hoechst 33342. The number of γ-H2AX foci was counted with an In Cell Analyzer 2000 (GE Healthcare), divided by the total number of cells, and expressed as the γ-H2AX foci per number of cells. To reduce individual differences in the baseline number of γ-H2AX foci in the in vivo study, we also calculated the rate of the γ-H2AX increase using the formula [(γ-H2AX at 15 min after CT) -(γ-H2AX before CT)] / (γ-H2AX before CT).
In vitro study

Phantoms
We used elliptical cisterns to create phantoms of three sizes to simulate the human trunk. Their walls were made 8-mm-thick acrylate resin. The elliptical cisterns were 35 (Fig. 1) . We filled each cistern with a gelatine solution (concentration 5.0% weight). Each phantom featured a 1.5-cm-diameter, 10-cm-long hole in the centre for the insertion of syringes.
Subjects
We obtained blood samples from the antecubital vein of five normal volunteers (three males, two females, median age 40 years, range 29-53 years). They had no history of cancer.
CT scan
Each blood sample was placed in the centre hole of the phantom and scanned on a 320-detector CT scanner (Aquilion One; Toshiba Medical Systems, Otawara, Japan) in volume scan mode (axial scan). The scan parameters were 100 kVp, rotation time 0.275 s, preset noise value 22, and detector configuration 320 × 0.5 mm.
In the usual scan it was difficult to adjust the CTDI to just 50, 100, and 150 mGy because we could not continuously change the tube current or scan duration and only discretely change them. Therefore we used ECG-gated dose modulation and a simulated ECG signal to obtain a radiation dose of 50, 100, and 150 mGy. The window for the full tube current (700 mA) was restricted based on the R-R interval. Outside the window of full radiation, the tube current was reduced by 80%. The R-R interval and heartbeat for data acquisition at 50, 100, and 150 mGy were 20-80% and one beat, 55-80% and three beats, 40-80% and four beats, respectively. The simulated heart rate was set to 60 beats per minute in all scans. One sample, representing the control, was not scanned.
To obtain the actually measured absorption dose we inserted glass dosimeters in the centre hole of the phantom and scanned it ten times using the same parameters as for the blood samples.
In the other series, the blood samples were inserted into the centre hole of cisterns representing small-, medium-, and large-sized phantoms. The antero-posterior (AP) and lateral (LAT) dimension of the small, medium, and large phantoms were 15 and 25 cm, 18 and 30 cm, and 21 and 35 cm, respectively. The tube current was set at 1749 mAs to be displayed as a CTDI of 100 mGy. The other scan parameters were the same as listed above. The SSDE was calculated by using the CTDI value reported on the scanner; size-dependent conversion factors were obtained from AAPM Report 204 [19] . These factors were based on the sum of the [AP] and [LAT] in each phantom.
In vivo study
Patients
The subjects were 45 patients (40 males, 5 females; median age 63 years, range 30-76 years) with atrial fibrillation, atrial flutter, and atrial tachycardia who were scheduled for radiofrequency ablation. They had no history of renal dysfunction (eGFR >30 ml/min/1.73m 2 ), asthma, or allergy to contrast agents; two patients had gastric and three had colorectal cancer. None had suffered cancer recurrence, and none had undergone radiation therapy or chemotherapy. We obtained their blood samples before and 15 min after CT and before ablation therapy (1-4 days after CT, median 2 days).
CT scan
Before radiofrequency ablation, all patients underwent cardiac CT with retrospective ECG gating on a 320-(Aquilion ONE, Toshiba Medical Systems Corp., Tokyo, Japan) or a 64-detector CT scanner (LightSpeed VCT, GE Healthcare, Waukesha, WI, USA). The scan parameters are shown in Table 1 . Non-ionic contrast material (300 mgI per kg body weight) was administered in the course of 12 s to all patients. A non-contrast-enhanced scan was acquired to measure the calcium score in all patients; this was followed by contrastenhanced scanning. We recorded the CTDI and the DLP displayed on the CT consoles. In each subject the SSDE was calculated as in the phantom studies.
Statistical analysis
In the in vitro study we used the Pearson correlation coefficient (r) to analyse linear relationships between the mean number of γ-H2AX foci and the CTDI or SSDE and between the CTDI and the actual absorption dose. We did not study the correlation between the DLP and the mean number of γ-H2AX foci because the DLP was the CTDI multiplied by the scan length, which was constant in vitro.
In the in vivo study we used the Tukey-Kramer multiple comparisons test to assess the difference between the mean number of γ-H2AX foci before and after CT, between their number after CT and before ablation, and between their number before CT and before ablation. We also used the Pearson 
Results
In vitro study: DNA damage by CT In the control, at CTDI 50, 100, and 150 mGy, the mean number of γ-H2AX foci was 0.94 ± 0.24 (SE), 1.28 ± 0.30, 1.91 ± 0.47, and 2.16 ± 0.20 foci/cell, respectively (Fig. 2) ; it was significantly correlated with the CTDI (r = 0.987). The actually measured absorption dose at a CTDI of 50, 100, and 150 mGy was 47.2 ± 1.5 (SD), 93.6 ± 5.0, and 147.7 ± 6.6 mGy, respectively. The DNA damage induced by CT was significantly correlated with the radiation dose.
The mean number of γ-H2AX foci was 2.41 ± 0.20, 1.91 ± 0.47, and 1.42 ± 0.20 foci/cell in the small, medium and large phantom, respectively (Fig. 3) . The corresponding SSDE was 180, 156, and 135 mGy, respectively. The mean number of γ-H2AX foci was significantly correlated with the SSDE (r = 0.999); the smaller the body size, the larger was the DNA damage induced by CT irradiation.
In vivo study: DNA damage by cardiac CT Blood samples were obtained before and 15 min after CT and again a few days after CT. The mean number of γ-H2AX foci at those time points was 1.21 ±0.19, 1.92 ± 0.22, and 1.06 ± 0.15 foci/cell, respectively (Fig. 4) . Their number was significantly increased after CT and returned to the baseline level a few days thereafter. There was a significant difference between the mean number of γ-H2AX foci before and after CT (p = 0.02) and between their mean number after CT and before ablation (p < 0.01). There was no statistically significant difference between the mean number of γ-H2AX foci before CT and before ablation (p = 0.83).
The mean CTDI, DLP, and SSDE value was 102.5 ± 46.5 mGy, 1560.5 ± 736.2 mGycm, and 138.2 ± 62.5 mGy, respectively. The CTDI was significantly correlated with the increase in the rate of γ-H2AX foci (r = 0.537, p < 0.001) (Fig. 5a) . The AIC for the linear correlation model between the CTDI and the rate of the γ-H2AX increase was 62.4. The DLP was also significantly correlated (r = 0.537, p < 0.001) (Fig. 5b) ; the AIC was 62.2. Lastly, the SSDE was also significantly correlated (r = 0.540, p < 0.001) (Fig. 5c) ; the AIC was 62.0. The mean of (AP+LAT) was 56.2 ± 4.3 (SD) cm, respectively. DNA damage was induced by radiation exposure in patients undergoing cardiac CT and the DNA damage induced by CT was significantly correlated with the physical exposure parameters addressed in our study.
Discussion
In our in vitro study the CTDI and the SSDE were strongly correlated with the mean number of γ-H2AX foci. In vivo, the CTDI, DLP, and SSDE were significantly correlated. Based on these results, we conclude that these three physical parameters for the radiation output from CT scanners may be predictive of DNA damage in lymphocytes. In our in vivo study, the correlation coefficient between the increase in the rate of γ-H2AX foci and the CTDI, the DLP, and the SSDE was very similar although the AIC for the SSDE was slightly smaller than for the other parameters. Therefore, the SSDE may be the best parameter for estimating the γ-H2AX level. The SD for our patients [AP+LAT] was 4.3 cm and much smaller than for North American patients (7.4 cm) [14] . Thus the variance in our subjects' constitution was smaller. This may have contributed to the observation that the correlation coefficient between the increase in the rate of γ-H2AX foci and the CTDI and the SSDE was almost the same in our study.
Although there was a statistically significant correlation between the physical exposure parameters and the increase in the rate of γ-H2AX foci in the in vivo study, the correlation coefficient was not high. This may be attributable to our use of contrast agents; they amplify DNA damage in patients undergoing CT studies because of the generation of secondary electrons when radiation interacts with the contrast agent [20, 21] . Inter-individual differences such as the sensitivity to radiation, a cancer or smoking history [18] , specific diseases [22, 23] , and differences in the number of foci, which change with the post exposure time [24, 25] , may also contribute to the rate of the γ-H2AX increase and these factors may affect the correlation between physical CT indices and the γ-H2AX level.
In our in vivo study we obtained blood samples 15 min after CT. In an earlier study, the half-maximum for γ-H2AX foci was observed 60 s after the exposure of cell cultures to radiation; the maximum was observed 10 min post-exposure [16] . Others reported that the number of γ- Fig. 5 Graph showing a significant correlation between the rate of the γ-H2AX increase and the CT dose index (CTDI) (a), the dose length product (DLP) (b), and the size-specific dose estimate (SSDE) (c). There was a statistically significant positive correlation between the γ-H2AX increase and the CTDI, DLP, and SSDE Fig. 4 Graph showing the number of γ-H2AX foci before CT, 15 min after CT, and a few days after CT. The number of γ-H2AX foci was significantly increased after CT (from 1.21 ± 0.19 to 1.92 ± 0.22 foci/cell); it returned to the baseline after a few days (1.06 ± 0.15 foci/cell) H2AX foci increased within the first 5 min post-exposure and thereafter decreased until 30 min after radiation [7] . These observations indicate that γ-H2AX formation is a rapid response to radiation exposure and they render our timing of blood sampling reasonable in view of the procedure and the blood circulation time.
DNA damage can lead to cell death and a wide variety of genetic alterations [17, 26] . Although most DNA damage is repaired rapidly and accurately by non-homologous end joining and homologous recombination, some DNA damage is not repaired accurately and this may change the genetic information. In our in vivo study the mean number of γ-H2AX foci returned to near the baseline level within a few days after CT. This is indicative of on-going repair of DNA damage [7] . However, the accumulation of even a small amount of misrepaired DNA damage may be carcinogenic although it is not known how much DNA damage may subsequently elicit carcinogenesis. To elucidate the relationship between increased DNA damage and cancer risks in patients undergoing CT, larger samples and long-term follow-up are needed [27] .
Earlier studies reported that DNA damage was induced by CT [7, [28] [29] [30] [31] [32] . In cardiac CT, mainly the heart is exposed to radiation because the lungs surrounding it are highly radiolucent and irradiated blood is rapidly ejected into peripheral vessels throughout the body. In our in vivo study we measured the γ-H2AX level in peripheral blood lymphocytes after cardiac CT and we suggest that it reflects radiation-induced DNA damage more accurately than do CT studies of other organs.
DNA damage induced by cardiac catheterisation has been documented [33] [34] [35] [36] . The radiation dose of cardiac CT was higher in our study than in these reports [31, [33] [34] [35] because all of our patients had arrhythmia and we could not adapt dose reduction techniques using a prospective ECG gating scan. We think that a direct comparison of our and earlier investigations is inappropriate because of differences in the methodology of radiation delivery (CT vs. fluoroscopy), the kind of biomarkers, and the timing of blood sampling; however, we should make an effort to reduce the radiation dose at cardiac CT.
The use of tube current modulation, lower tube voltages, noise reduction filters, and iterative reconstruction algorithms is aimed at reducing the radiation dose [37, 38] . While these techniques can decrease the radiation dose by 20-80%, it is yet unknown at what dose DNA damage is likely to occur. Studies are needed to determine whether DNA damage can occur with low-dose CT scanning.
Our study has some limitations. First, we calculated DNA damage in peripheral blood lymphocytes because they are easily obtained. To reveal the risk for cancer of, for example, the breast and lung, invasive procedures to harvest organ tissue must be performed. Second, we did not calculate the organ, blood, and effective doses. For their calculation, patient dosimetry calculators such as ImPACT CT or CT-Expo are necessary. However, they are not suitable for cardiac CT because ECG modulation is used for cardiac CT scans. Third, although we tried to obtain blood samples at just 15 min after CT to minimise the post-exposure, timedependent variation in the number of γ-H2AX foci, it was difficult to obtain blood samples after that exact interval in all patients. Even slight timing differences may affect the number of detected γ-H2AX foci. Fourth, we calculated the SSDE from geometric data based on AAPM Report 204 [19] . An SSDE calculated from the water-equivalent diameter is more accurate than the SSDE calculated from geometric data. However, use of the water-equivalent diameter is relatively new and not yet widely applied. Moreover, this method is somewhat complex and no specific software for calculating the water-equivalent diameter is currently available [39] . Assessments using the SSDE calculated from the waterequivalent diameter are needed.
In conclusion, DNA damage was induced by radiation exposure from cardiac CT. There was a significant correlation between the CTDI, DLP, and SSDE and the induction of γ-H2AX foci. The actual effect of CT radiation exposure of the body can be estimated from these physical exposure parame ters.
